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ABSTRACT 
Trypanosoma cruzi is a kinetoplastid parasite that causes Chagas disease. Trypanosomes are unusual organisms in many aspects of its 
genetics and molecular and cellular biology and considered a paradigm of the exception of the rule in the eukaryotic kingdom. The 
complete genome sequence of T. cruzi was published in 2005, thus, providing a major tool to the understanding of several of his unusual 
aspects. However, with so many different mechanisms between the parasite and its mammalian host there is still a lack of availability of 
effective antiparasitic drugs or disease treatments, specially in the chronic phase. This review highlights the fundamentals of the fasci-
nating genetics and genomics of T. cruzi with emphasis in the differential mechanisms that could provide interesting therapeutic targets. 
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INTRODUCTION: AN OVERVIEW OF 
TRYPANOSOMA CRUZI AND CHAGAS DISEASE 
 
Trypanosoma cruzi causes Chagas disease in humans. The 
disease is endemic in Latin American countries, where 16-
18 million people are affected with more than 20,000 
deaths reported each year (Prata 2001; Dias et al. 2002). 
The acute infection can be lethal, but the disease usually 
evolves to a chronic asymptomatic phase. However, in 25-
30% of cases develops symptoms like cardiomyopathy or 
lesions in gastrointestinal tract which ultimately lead to 
death. The chronic phase is characterized by low parasite-
mia but parasites persist inside cells and are often associ-
ated to the sites of lesions (Brener and Gazzinelli 1997; 
Levin 1996; Tarleton and Zhang 1999; Schijman et al. 
2004). 
T. cruzi belongs to the subkingdom protozoa, order 
kinetoplastida, a group which also includes Trypanosoma 
brucei (sleeping sickness) and Leishmania major (Leishma-
niasis). The three model organisms are collectively known 
as the Tritryps. The T. cruzi life cycle includes two hosts, 
one invertebrate and one vertebrate as it is transmitted by 
triatomine insects. The parasite exists in different forms in 
different stages of its life cycle. It is ingested by the triato-
mine as trypomastigote in the blood meal but rapidly trans-
forms into epimastigote in the midgut and transforms back 
into trypomastigote in the hindgut. In the vertebrate host, 
the parasite travels in the bloodstream as trypomastigote but 
transforms into amastigote inside cells (Fig. 1) (Tyler and 
Engman 2001). 
Two different ecosystems exist for T. cruzi: the sylvatic 
cycle occurring in wild hemiptera and generally involving 
mammals and the domestic cycle dependant on home-
dwelling hemiptera and humans and household animals. 
The connection between the two is made by infected rats, 
mice, bats and marsupials. It is postulated that the parasite 
emerges over 150 million years ago originally infecting pri-
mitive mammals in the regions that originated North and 
South America but the contact with humans occurs more 
recently, in the late Pleistocene, 15,000-20,000 years ago 
(Briones et al. 1999). It was demonstrated the presence of T. 
cruzi in infected mummies from Northern Chile and Sou-
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thern Peru dated 9,000 years before present day (Aufder-
heide et al. 2004) 
Initially, two major evolutionary lineages have been 
identified and named T. cruzi I and T. cruzi II associated 
with the sylvatic and domestic cycles, respectively. T. cruzi 
II was also associated with severe manifestations of the 
disease (Briones et al. 1999; Zingales et al. 1999). However, 
further inspection of genomic data combined with new ana-
lytical techniques showed that T. cruzi II could be subdi-
vided into five phylogenetic sublineages (IIa-e) and there 
were also hybrid strains belonging to groups 1/2 (Brisse et 
al. 2000; Macedo et al. 2004). The occurrence of hybrid 
strains in natural populations suggests that sexual events 
definitely have taken place in the past and have shaped the 
current genetic structure of T. cruzi populations. At present, 
it is accepted that the ancestral lineages were three, T. cruzi 
I, II and III. At least, two hybridization events involving T. 
cruzi II and T. cruzi III produced evolutionarily viable pro-
geny in which the first was identified as the recipient and 
the latter as the donor by the mitochondrial clade of the 
hybrid strains (de Freitas et al. 2006). It is assumed that the 
complete understanding of the population structure in T. 
cruzi will be indispensable for an effective control of the 
disease by controlling especially the sylvatic cycle. 
 
How is Chagas disease treated in patients? 
 
Specific treatment of Chagas disease with chemotherapy 
has been controversial; instead previous control of the para-
site reservoirs could be essential. Currently available che-
motherapy based on nitrofurtan (nifurtimox, Lampit® 
Bayer) and nitroimidazole (Benznidazole, Radanil® Roche) 
is unsatisfactory because of their limited efficacy in the pre-
valent chronic stage of the disease and their toxic side ef-
fects (Docampo 1990). Their activities were discovered 
empirically over three decades ago. Nifurtimox acts via the 
reduction of a nitro group to produce highly toxic, reduced 
oxygen metabolites. T. cruzi has been shown to be deficient 
in detoxification mechanisms for oxygen metabolites and is 
thus more sensitive to oxidation stress than are vertebrate 
cells. Benznidazole seems to act via a reductive stress me-
chanism, which involves covalent modification of macro-
molecules by nitroreduction intermediates. Both nifurtimox 
and benznidazole have significant activity in the acute 
phase but very limited antiparasitic activity in the chronic 
form of the disease. Side effects include anorexia, vomiting 
and allergic dermopathy (Urbina and Docampo 2003). 
New approaches to specific chemotherapy are under 
development. Biochemical routes such as the de novo sterol 
biosynthesis pathway, cysteine protease inhibitors or pyro-
phosphate metabolism have been chemically validated and 
are poised for clinical trails in the near future. Other promi-
sing approaches include interference with trypanothione 
synthesis, redox metabolism or protein complexes (protea-
some, spliceosome, etc.) that may present differences with 
that of the host (Urbina and Docampo 2003; Vazquez et al. 
2003). 
The role of T. cruzi in the aetiology of chronic Chagas 
disease has been the subject of many debates. Several stu-
dies strongly implicated autoimmune phenomena as the pri-
mary factor leading to the pathogenesis of the disease. This 
hypothesis is based on the apparent absence of parasites in 
the inflammatory lesions and the presence of anti-self anti-
bodies. These antibodies were postulated as the result of a 
“molecular mimicry” between parasite and host antigens 
(Levin 1996). 
However, recent works found that the severity of the 
disease correlated strongly with the persistence of T. cruzi 
antigens that coupled with an unbalanced immune response 
in some individuals can lead to the sustained inflammatory 
response in infected tissues (Tarleton 2001). 
Overall, elimination of T. cruzi from infected chronic 
Chagas patients would be a prerequisite to arrest the evolu-
tion of the disease and avoid its long-term consequences. 
 
A GENETIC OVERVIEW 
 
Gene organization and transcription: The 
exception to the rule in the eukaryotic kingdom 
 
Trypanosomes are intriguing and amazing organisms in 
many aspects of their biology. In fact, they managed to 
emerge as the paradigm to “the exception of the rule” in the 
eukaryotic lineage during the last decade. However, what 
was considered “rare and exceptional” in these organisms 
was later shown to be more common than previously 
thought in the eukaryotic kingdom such as the mRNA trans-
splicing or RNA editing processes. 
Fig. 1 Life cycle of Trypano-
soma cruzi. The vector Triatoma 
infestans takes a blood meal and 
leaves metacyclic trypomastigotes 
in the feces. Trypomastigotes 
enter wound bite and travel in the 
bloodstream. Later they are able 
to infect various cell types and 
transform into amastigotes which 
multiply by binary fission. In the 
end, the cells with amastigote 
nests explode and the parasites 
transform back into trypomasti-
gotes which continue the cycle in 
the vertebrate host. Eventually, a 
triatomine bug takes a new blood 
meal and the parasites transform 
to epimastigotes in the midgut 
where they multiply by binary 
fission. They transform to 
infective metacyclics in the 
hindgut. 
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The bottom line to understand the particular trypanoso-
matid genetics is the absence of typical RNA polymerase II 
promoters for protein-coding genes in their genomes. 
The question raised from the previous statement is chal-
lenging: how can the trypanosome genes be transcribed and 
expressed? The answer is more challenging: we do not 
know. 
 The fact is that mRNAs are expressed as large poly-
cistronic transcription units (PTUs) composed of unrelated 
genes. These PTUs could be as large as a whole chromo-
some. In the end, the PTUs are processed to monocistronic 
mRNAs by two coupled reactions, trans-splicing and poly-
adenylation, and exported to the cytoplasm for translation 
(Clayton 2002; Monnerat et al. 2004; Martinez-Calvillo et 
al. 2004). Thus, mRNA maturation in trypanosomes differs 
from the process in most eukaryotes (Fig. 2A). 
It is postulated that one or few transcription initiation 
sites are present per chromosome. Why is so difficult to 
find polymerase II promoters in trypanosomes? Mainly be-
cause the 5′ start site is lost during mRNA processing and 
the large polycistronic intermediates are very short-lived. 
The chromosome I of Leishmania major is a very good 
example. It is 270 kb long and harbors 79 genes, fifty of 
which are transcribed towards one telomere while the re-
mainder are transcribed towards the other as single opposite 
PTUs (Martinez-Calvillo et al. 2003). The two units are 
separated by a small 1.6 kb-long region in which several 
transcription start sites could be located in both directions. 
The minimal region with no transcription was mapped to a 
73 nucleotide-long sequence which resembled none of the 
known eukaryotic promoter sequences and with a C-rich 
tract as the only recognizable feature (Martinez-Calvillo et 
al. 2003). It was named the strand switch region because 
somehow it managed to direct transcription in both direc-
tions. How does it work? It is not possible to answer that at 
present. 
More intriguing is the fact that chromosome III is orga-
nized and transcribed in a very similar fashion but the 
strand switch regions in each one of these chromosomes 
share no sequence homologies (Worthey et al. 2003; Marti-
nez-Calvillo et al. 2004). 
One possible explanation is that, in trypanosomes, trans-
cription by RNA polymerase II is not directed by sequence 
elements but by structural elements such as an unwound 
chromatin region. This is known as the “landing pad” theory 
and proposes that polymerase II lands wherever it founds a 
more relaxed state of the chromatin to start transcription. 
Despite these peculiarities, trypanosomes have highly 
conserved copies of the three eukaryotic RNA polymerases 
(Pol I, Pol II and Pol III). 
Surprisingly, two protein-coding genes are transcribed 
by Pol I and not Pol II in Trypanosoma brucei. These two 
genes encode for the major surface proteins, PARP and VSG, 
which coat the complete parasite surface in procyclics and 
trypomastigotes forms respectively (Clayton 2002). These 
genes are also embedded in polycistronic transcribed units 
but present a well defined promoter which is exchangeable 
with the Pol I ribosomal promoter. Remarkably, T. brucei is 
the only known organism that transcribes a protein-coding 
gene using Pol I which is exclusively used for ribosomal 
RNA transcription in all eukaryotes. The problem is that Pol 
I do not have an associated capping activity to protect the 
mRNA 5′ end. Thus, transcription of protein-coding genes is 
restricted to Pol II and its associated capping enzyme. 
How did T. brucei solve this apparent problem? The an-
swer behind this secret is in the RNA processing machinery, 
the trans-splicing reaction, which will be discussed below. 
In contrast, T. cruzi cells do not present any Pol I trans-
cribed protein-coding gene unless they are genetically engi-
neered to do so. 
Why does T. brucei adopt Pol I for the production of 
PARP and VSG coat proteins? 
The Pol I promoter is very strong and sustains high 
levels of transcription rates which is ideal for the production 
of a massive amount of these surface proteins needed by the 
parasite. 
Since T. cruzi and L. major developed intracellular 
forms and do not have Pol I transcription, this could be a re-
latively new trick adopted by T. brucei to adjust to its extra-
cellular life-style. 
As a consequence of this mode of polycistronic trans-
cription, the genes are densely packed in the genome sepa-
ORF1 ORF2pPY tract
Promoter??
DNA
Trans-splicingPolyadenylation
Pre-mRNA
??
pPYAG AG(A)
SL
SL SL
AAAAn mRNAs
TAACGAGTTTCTTCAAAATATGCAGCGGATTCACTAAGAAACATTTTCACGCACGAAAGCGAAATTATTA
TGATTGTTATTATAATACTTTTTCTTTGTTGTTTTATCCACTTATTATTGTTGTGTTAAATTGTTTTTACCTTTT
TTCTTTTCCAACTTCTTTTATGATGTCTTTTCTTTTTTTTTTTTTTGCTCTATAAGTTGTCTTGTCAGATG
Anatomy of a typical T. cruzi intergenic region
AAAn
A
B
Fig. 2 Summary of polycistronic transcription and RNA processing events in trypanosomes. (A) Highlighted are several important features: the
absence of defined RNA Pol II promotores, generation of polycistrons and coupled trans-splicing/polyadenylation coordinated by a polypyrimidine tract
(pPY) in the intergenic region. Trans-spliceosome complex is identified by a shaded balloon with question marks to indicate that the majority of its
components are yet to be determined. The AG is the splice acceptor site of the SL RNA and the (A) represents an adenine residue that is usually the
acceptor of the poly A tail. (B) Anatomy of a typical intergenic region in T. cruzi represented by the HX1 sequence used in the expression vector pTREX.
In italics is highlighted the pPY tract, in italics and underline, the splice acceptor site and in rectangles, the stop codon of the gene upstream and the start
codon of the gene downstream. 
TAACGAGTTTCTTCAAAATATGCAGCGGATTCACTAAGAAACATTTTCACGCACGAAAGCGAAATTATTA
TGATTGTTATTATAATACTTTTTCTTTGTTGTTTTATCCACTTATTATTGTTGTGTTAAATTGTTTTTACCTTTT
TTCTTTTCCAACTTCTTTTATGATGTCTTTTCTTTTTTTTTTTTTTGCTCTATAAGTTGTCTTGTCAGATG
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rated by short Intergenic Regions (IRs). These IRs could be 
as little as 150 bp long and they are always pyrimidine-rich 
(Fig. 2B). The IRs play a central role in mRNA processing 
and gene regulation assuming part of the responsibility that 
was left behind by the absence of Pol II promoters (Clayton 
2002). 
During the course of evolution of this genome organi-
zation, trypanosomes lost the vast majority of introns. In 
fact, only two intron-containing genes have been identified 
out of the 12,000 genes present in the T. cruzi genome, a 
Poly A Polymerase (PAP) gene and a DEAD-box type heli-
case gene (Mair et al. 2000; Ivens et al. 2005). 
The absence of typical Pol II promoters posed another 
challenging question: How gene regulation is controlled 
and regulated in the context of the complex life cycle of 
trypanosomes? 
 
TRANS-SPLICING mRNA PROCESSING AND 
POST-TRANSCRIPTIONAL REGULATION OF 
GENE EXPRESSION: MORE SURPRISES ON THE 
GO 
 
Promoters and enhancers are the key elements present in 
eukaryotic cells to achieve fine tuning regulation of gene 
expression to control complex situations such as develop-
ment, differentiation and multicellularity. Even deep-bran-
ching eukaryotes such as Giardia and Trichomonas have 
basal Pol II promoters to direct transcription (Vancova et al. 
2003). However, trypanosomes are a unique exception in 
this matter. 
In these parasites, regulation of gene expression for 
protein-coding genes is entirely post-transcriptional (Clay-
ton 2002). 
The first event coordinated by the IR sequence ele-
ments is the processing of polycistronic mRNA transcrip-
tion. Two reactions are needed to generate monocistronic 
mRNAs: trans-splicing and polyadenylation. The two 
events are coupled and coordinated by the same polypyri-
midine rich sequence present in the IR (Matthews et al. 
1994; Lebowitz et al. 2003). In this way, Poly A addition of 
the gene upstream is directed by the trans-splicing process-
sing of the gene downstream in the PTU. There is no spe-
cific signal for polyadenylation such as the AAUAAA in 
higher eukaryotes (Fig. 2A). 
 
Trans-splicing processing of RNAs 
 
Trans-splicing was discovered almost 20 years ago. It in-
volves to different molecules, the polycistronic RNA and a 
39 nucleotide sequence named Splice Leader (SL). It was 
later established that all trypanosome mRNAs undergo 
trans-splicing and, thus, acquired the SL common sequence 
in the 5′ end (Liang et al. 2003). 
The source of the SL sequence was found to be a small 
capped RNA transcribed by Pol II from thousands of SL 
RNA genes arranged in head to tail tandem. Surprisingly, 
the SL RNA genes are the only known to be transcribed 
from a well defined Pol II promoter. However, it is not a 
protein-coding gene. Trans-splicing proceeds through a 
two-step trans-esterification reaction, analogous to cis-spli-
cing but forming a Y structure instead of a lariat interme-
diate. The SL RNA precursor is a 140 nt long molecule that 
is capped in the 5′ end and carries a GU 5′ splice site (ss) 
donor downstream of the first 39 bases. The capping modi-
fication involves the first four bases of the SL sequence to 
form the so called “cap 4 structure” that is unique among 
eukaryotes. 
The reaction proceeds as follows: The GU 5′ ss is bran-
ched to an Adenosine in the IR of the pre-mRNA precursor 
and the SL sequence is free to react with the first available 
AG 3′ ss downstream. The Y structure intermediate is de-
graded and the SL is joined to the mature mRNA (Liang et 
al. 2003). 
Thus, the SL addition serves two purposes: it functions 
together with polyadenylation in dissecting the polycistro-
nic transcripts, and it provides the cap to the individual 
mRNAs. 
Although trans-splicing was first discovered in trypano-
somes, the process was later found in nematodes, trema-
todes, euglenoids and chordates (Hastings 2005). However, 
in these organisms, a minority of genes are processed in this 
way. 
Surprisingly, after almost a decade of searching for cis-
splicing in trypanosomes, two genes carrying a single cis-
spliced intron each were found (Mair et al. 2000; Ivens et al. 
2005), demonstrating that the two splicing processes coexist 
in trypanosomes as in every other organism capable of 
trans-splicing. 
After years of experiments, much was learned about the 
SL RNA biogenesis and its interactions with the small 
nuclear RNAs (snRNAs) to conform the trans-spliceosome 
complex (Liang et al. 2003). In contrast, very little is known 
about the splicing factors involved in the trans- and cis-spli-
ceosomes as well as the polyadenylation factors. Prelimi-
nary results showed interesting information suggesting uni-
que features of this complex respect to other eukaryotic or-
ganisms (Liang et al. 2003; Vazquez et al. 2003). Unravel-
ing the machinery of trans-splicing that does not exist on 
the host of this parasite gives hope for a therapeutic inter-
vention directed toward specific components of the trans-
spliceosome. 
Since trypanosomes lack control at transcription initia-
tion sites, regulation of gene expression depends entirely on 
post-transcriptional processes. 
Trans-splicing is the first step that could be the subject 
of post-transcriptional regulation. It has been shown that 
potential modulation of trans-splicing efficiency is possible 
(Vazquez and Levin 1999; Hummel et al. 2000; Ben-Dov et 
al. 2005). Exonic enhancers have been described in both T. 
brucei and T. cruzi (Lopez-Estranio et al. 1998; Ben-Dov et 
al. 2005). Moreover, modulation of splicing efficiency in T. 
cruzi has been shown to occur by the insertion of a short 
interspersed repetitive element (SIRE) carrying its own 
trans-splicing signals (Ben-Dov et al. 2005). 
Alternative trans-splicing was also demonstrated in T. 
cruzi. In fact, the Lyt1 gene, coding for a product of the lytic 
pathway, produces three different variants of mRNA by 
alternative trans-splicing. One of these mRNAs generates a 
short variant of Lyt1 lacking a N-terminal signal sequence 
(Manning-Cela et al. 2002) 
Recently, it has been shown that splice site-skipping is 
responsible for the regulation of some protein-coding genes 
in T. cruzi (Jager et al. 2007). The skipping process gene-
rates a bicistronic transcript that avoids the translation of the 
gene downstream. 
 
Events of post-transcriptional regulation after 
trans-splicing 
 
The next major step for post-transcriptional regulation is 
mRNA export and turnover in the cytoplasm. Several re-
ports indicate that this is one of the two more important 
steps to control gene expression in trypanosomes. The other 
is the control of mRNA translation (Clayton 2002; D’Orso 
et al. 2003). 
The control of mRNA half-life in the cytoplasm requires 
at least three actors: two to indicate specifically which 
mRNA needs to be stabilized or destabilized and another 
one as the effector (i.e., the exosome complex). To specify 
one particular type of mRNA, it is required cis-acting sig-
nals in the 5′ or 3′ untranslated regions (UTR) of the mRNA 
and protein factors to recognize them (Fig. 3). 
These proteins harbor RNA binding domains such as 
RRMs (RNA Recognition Motif), Zinc Fingers (CCCH or 
CCHC types) or PUF (Pumillio/FBF homology domains). 
In accordance with their choice of gene regulation, the 
genomes of trypanosomes contain several expanded fami-
lies of these types of proteins. Indeed, their genomes contain 
more than 100 proteins with RRM domains, more than 40 
proteins with CCCH zinc finger motives, around 20 proteins 
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with CCHC zinc knuckle motives and 10 PUF proteins (de 
Gaudenzi et al. 2005; Ivens et al. 2005; Caro et al. 2006). 
A subset of the RRM containing proteins fulfill house-
keeping functions such as the U2AF35 splicing factor (Vaz-
quez et al. 2003) and the Poly A binding Protein (PABP) 
but it was estimated that at least 50 RRM proteins perform 
trypanosome specific functions (de Gaudenzi et al. 2005). 
One of the first to be identified was TcUBP-1 in T. cruzi, a 
single RRM containing protein, involved in the in vivo de-
stabilization of SMUG (Mucin) mRNA in a stage specific 
manner (D’Orso and Frasch 2002). It was later shown that 
TcUBP-1 is a member of a larger family with five additio-
nal members (TcUBP-2, TcRBP-3, TcRBP-4, TcRBP-5 and 
TcRBP-6). The proteins TcUBP-1 and TcUBP-2 act toge-
ther in the epimastigote stage to bind AU-rich elements 
(AREs) present in the 3′ UTR of SMUG mRNA to stabilize 
the complex (D’Orso and Frasch 2001). Conversely, in the 
trypomastigote stage, TcUBP-2 is no expressed and 
TcUBP-1 alone binds the ARE element and the poly A bin-
ding protein TcPABP to destabilize the mRNA. The mRNA 
degradation pathway seems to proceed through the exo-
some complex (D’Orso et al. 2003). This complex was ful-
ly characterized in T. brucei and the orthologue proteins are 
present in the T. cruzi genome (Estevez et al. 2001; Haile et 
al. 2003). 
One of the most interesting examples of CCCH zinc 
finger proteins involved in post-transcriptional regulation is 
that of the ZFP1 and ZFP2. They are two small proteins of 
101 and 139 residues respectively that were first identified 
in T. brucei. They were implicated in regulated morphoge-
nesis and differentiation of the parasite (Hendriks et al. 
2001; Caro et al. 2005). Indeed, overexpression of ZFP2 
generated a posterior extension of the microtubule corset, a 
mechanism responsible for kinetoplast repositioning during 
differentiation. On the other hand, depletion of ZFP2 
severely compromised differentiation from bloodstream to 
procyclic forms and ZFP1 is in vivo enriched through dif-
ferentiation to procyclics. Four homologous proteins were 
found in the genome of T. cruzi, two ZFP1s (a and b) and 
two ZFP2s (a and b). It was demonstrated that the T. cruzi 
ZFP1 and ZFP2 families interact with each other via a WW 
protein interaction domain present in ZFP2 and the corres-
ponding binding site (a proline rich sequence) present in 
ZFP1 (Caro et al. 2005). It is postulated that heterodimmers 
ZFP1/ZFP2 bind RNA targets via the CCCH zinc finger 
and sequester the mRNA through proteasome degradation 
(Hendriks et al. 2001; Caro et al. 2005). The CCCH motif 
of T. cruzi ZFP1 was shown to bind C-rich sequences in 
RNA in vitro (Morking et al. 2004) but it is still unknown 
which are the mRNA targets of these proteins in vivo. 
The Pumilio protein family (PUF) is evolutionary con-
served and found exclusively in eukaryotes. These proteins 
bind 3′ UTR elements of their target mRNAs to reduce ex-
pression either by repressing translation or causing mRNA 
instability. All pumilio proteins share a domain of eight to 
nine imperfect repeats of 36-40 amino acids that binds to 
the core nucleotide sequence UGUR. On the basis of dif-
ferent studies, a common function established for these pro-
teins is the maintenance of stem cells by promoting proli-
feration and repressing their differentiation (Wickens et al. 
2002). In this way, it is expected that Pumilio proteins 
would have a central role in a programmed control of gene 
expression events during differentiation in trypanosomes. 
The PUF proteins reported for T. cruzi are double the num-
ber of PUF proteins present in yeasts, five times the number 
in mammals and other parasites such as Plasmodium falci-
parum and are comparable with the number present in ne-
matodes (Caro et al. 2006). 
A bioinformatic analysis in T. cruzi has provided some 
putative important mRNA targets for some of the PUF pro-
teins (Caro et al. 2006). One of them is the mRNA for the 
nuclear encoded Cox5 subunit of the mitochondrial cyto-
chrome oxidase whose protein product is developmental re-
gulated but the results await in vivo confirmation (Caro et al. 
2006). Depletion of PUF1 in T. brucei has no effect on para-
site viability, indicating that redundancy may occur in the 
trypanosome PUF protein family (Luu et al. 2006). 
Besides all these examples of regulation by cis-acting 
sequences in the 3′ UTR of mRNA, few examples also indi-
cate that signals in the short 5′ UTRs could modulate trans-
lation such as the case of the TcP2β ribosomal protein 
mRNA (Ben-Dov et al. 2005). 
In Fig. 3, different events of post-transcriptional regula-
tion that have been documented in T. cruzi are summarized. 
 
TOOLS FOR GENETIC MANIPULATION OF T. 
CRUZI 
 
During the last decade, various genetic tools have been in-
troduced that allow manipulation of trypanosomatid gen-
omes. Many of these are adapted from other eukaryotic 
model organisms, and the task for molecular parasitologists 
has been to get them to work in parasites that pose unique 
challenges. The genetic “toolkit” includes techniques that 
allowed researches to investigate gene function by both 
gain- and loss-of-function strategies and to study localiza-
tion of their protein products using in vivo tagging strategies 
such as Green Fluorescent Protein (GFP). 
Main efforts to set up these techniques have been made 
in T. brucei and Leishmania while T. cruzi has been left far 
behind during many years. 
It is clear that the differences in the genetic tools that are 
available for the different parasites have marked an impact 
on the kinds of questions that researches are pursuing in 
these organisms. 
Moreover, one of the most powerful tools available to 
study gene function is knockdown by RNA interference, or 
RNAi (Beverley 2003). RNAi was successfully established 
and widely used in various model organisms mainly because 
of its simplicity and efficiency. Gene silencing by RNAi is 
SL
ORF
3´UTR
AAAAn
cis-acting
sequence
RRM
Zinc finger
PUF
Stabilization
Degradation
Exosome
Enhanced translation
Trans-splicing efficiency cis-acting sequence
Enhanced translation
Fig. 3 Summary of the post-
transcriptional events of 
gene regulation documented 
in T. cruzi. Protein factors 
with RRM, zinc fingers 
(CCCH) or PUF domains bind 
cis-acting sequences in the 3′ 
untranslated regions (UTR) 
and trigger two events: stabili-
zation or degradation of 
mRNAs. Cis-acting sequences 
in the 5′ UTRs also enhance 
translation of the mRNA. In 
general, the 3′ UTRs are larger 
than the 5′ UTRs. Trans-spli-
cing efficiency also affects the 
abundance of mRNAs. 
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well established in T. brucei and several successful reports 
are available in the literature including a chromosome-wide 
analysis of gene function (Motika and Englund 2004; Ullu 
et al. 2004; Subramaniam et al. 2006). However, efforts to 
use this tool in Leishmania (Robinson and Beverley 2003) 
and T. cruzi (da Rocha et al. 2004) were completely unsuc-
cessful. Recently, with the genome sequence finished and 
annotated, it was discovered that T. cruzi lacks some essen-
tial components of the RNAi pathway machinery such as 
the argonaute 1 (Berriman et al. 2005) and the dicer-like 
protein (Shi et al. 2006) present in T. brucei. 
The absence of RNAi in T. cruzi introduced a great 
limitation to the functional genetics in this parasite. 
Thus, analysis of gene function relies exclusively on 
more difficult and time-consuming techniques such as gene 
deletion or dominant negative approaches. As a disadvan-
tage, gene deletion could only be applied depending on the 
gene copy number present in the genome and as advantage, 
homologous recombination works particularly well in try-
panosomatids (Beverley 2003). Few reports have success-
fully created null mutants for non-essential genes such as 
the T. cruzi surface glycoprotein GP72, a single copy gene 
(Cooper et al. 1993). Instead, attempts to disrupt essential 
genes resulted in a remarkable emergence of aneuploid or 
polyploidy parasites, an unusual outcome that is now used 
as a criterion for weather the targeted gene is essential or 
not (Beverley 2003). 
Besides, in vitro culture models and transient and stable 
DNA transfection systems for T. cruzi are well established 
(da Rocha et al. 2004b). Development of DNA transfection 
vectors was challenging since trypanosomes have no well 
defined promoters or other structural elements such as ori-
gin of replications or centromeres. Initial constructions have 
taken into account the importance of the intergenic regions 
in RNA processing and stability. In this way, the first trans-
fection vector available for T. cruzi was pTEX (Kelly et al. 
1992) which harbors no promoter sequence but contains the 
IRs of the gapdh gene surrounding a polylinker cloning site 
and a selectable marker (NEO) for G418 resistance. This 
vector allowed stable transfection of T. cruzi and unregu-
lated overexpression of protein products. The pTEX is 
maintained as a circular episome of multiple head to tail 
units of the original transfected plasmid. To obtain higher 
overexpression levels, the amount of G418 is raised and 
concomitantly more plasmid units were added to the multi-
meric episome. The results also demonstrated that there is 
no need for Pol II promotores and that the elements in the 
IRs have taken all the control of gene expression. 
Subsequently, a second generation of expression vec-
tors were developed using the pTEX backbone such as 
pRIBOTEX (Martinez-Calvillo et al. 1997) and pTREX 
(Vazquez and Levin 1999). These vectors introduced two 
new features: a strong ribosomal promoter for Pol I trans-
cription (pRIBOTEX) and a strong trans-splicing signal 
named HX1 associated downstream (pTREX) (Figs. 2B, 
4A). The presence of HX1 in pTREX highlights the impact 
of the RNA processing signals on gene expression in T. 
cruzi. When RNA processing is directed by a cryptic and 
weak trans-splicing signal in pRIBOTEX, the difference on 
the levels of gene expression between the two vectors is 
huge (Fig. 4B, 4C). 
These vectors are spontaneously inserted into the ribo-
somal locus as single copy instead of being maintained as 
episomes. The high recombinogenic activity is stimulated 
by a short 86 nucleotides long sequence within the riboso-
mal promoter region (Lorenzi et al. 2003). In this way, 
pTREX obtains very high levels of overexpression, it is 
more stable than pTEX and it was used successfully in seve-
ral genetic analyses (Vazquez et al. 2003; da Rocha et al. 
2004a; Guevara et al. 2005). 
However, more complex analyses of gene function re-
quire the use of an inducible expression system. Such a sys-
tem was present for years in T. brucei (Wirtz and Clayton 
1995) but it was not developed until recently in T. cruzi by 
two different groups (da Rocha et al. 2004a; Taylor and 
Kelly 2006). One of these tetracycline-regulated expression 
vectors, pTcINDEX, was developed using elements from 
the T. brucei system and pTREX. The expression is under 
the control of a tetracycline-regulatable T7 promoter and it 
was tested using two markers, luciferase and Red Fluores-
cent Protein (RFP). The induction was both time and dose 
dependant and the system could be induced at least 100-fold 
within 24 hs of the addition of tetracycline (Taylor and 
Kelly 2006). The vector pTcINDEX represents a valuable 
addition to the genetic tools available for T. cruzi and the 
system is ready for the use in dominant negative approaches 
in the near future. 
 
A GENOMIC OVERVIEW 
 
The genome sequence of T. cruzi 
 
Trypanosoma cruzi is diploid and presents different-sized 
homologous chromosome pairs (Pedroso et al. 2003). Since 
the chromosomes do not condense in metaphase, direct ka-
ryotypic analysis is not possible. Thus, its number has been 
estimated by the use of Pulsed Field Gel Electrophoresis 
(PFGE). Current estimates indicate the presence of 28 chro-
mosomes per haploid genome (Branche et al. 2006). How-
ever, the exact number is not known because homologs can 
differ substantially in size complicating the PFGE analysis. 
The T. cruzi genome project was challenging. Its ge-
nome sequence was accomplished as part of a project to 
obtain the sequence of the three model kinetoplastids along 
Fig. 4 Expression vectors. (A) Schematic representation of two of the 
most widely used gene expression vectors in T. cruzi carrying a green 
fluorescent protein (GFP) gene. High rates of transcription are directed by 
the RNA Pol I ribosomal promoter (Rib. Prom.). Vertical arrows indicate 
the splice acceptor site for SL RNA addition in each case. HX1 is an inter-
genic region that harbors a strong trans-splicing signal. Neo is the G418 
resistance gene that is surrounded by intergenic regions from the T. cruzi 
gapdh gene. (B) Estimation of GFP fluorescence in transgenic parasites 
transfected either with pTREX-GFP or pRIBOTEX-GFP using a fluoro-
meter. (C) Estimation of fluorescence of the same parasites in B but as 
observed under fluorescence microscopy. There is almost a 100x dif-
ference between pTREX and pRIBOTEX due exclusively to the intergenic 
region HX1. 
6
The genetics and genomics of Trypanosoma cruzi. Martin P. Vazquez 
 
with T. brucei and L. major, the Tritryps (Berriman et al. 
2005; El-Sayed et al. 2005a, 2005b; Ivens et al. 2005). 
The T. cruzi strain CL Brener is a member of the sub-
group IIe and was chosen for sequencing because it is well 
characterized experimentally. However, it was later disco-
vered that it is a hybrid strain between T. cruzi I and T. cruzi 
II lineages. This fact complicated the efforts to obtain the 
whole genome sequence and its assembly and it was later 
necessary to generate a 2.5X sequence coverage of the Es-
meraldo strain from the progenitor subgroup IIb to allow 
distinguishing the two haplotypes. Moreover, the sequence 
coverage for CL Brener strain was 19X with more than 768 
Mb obtained in single reads, one of the largest for any eu-
karyotic genome sequenced to date. 
It was finally published in July, 2005 in a special edi-
tion of Science with the genomes of the other Tritryps (El-
Sayed et al. 2005b). 
The sequence was obtained by using the whole-genome 
shotgun (WGS) technique because the high repeat content 
limited the initial “map-as-you-go” bacterial artificial chro-
mosome (BAC) clone-based approach. The assembly para-
meters were modified to contend with the high allelic vari-
ation of the genome. 
The current T. cruzi assembly contains 5489 scaffolds 
totaling 67 Mb. On the basis of the assembly, the T. cruzi 
diploid genome size was estimated between 106.4 and 
110.7 Mb. A total of 60.5 Mb comprised the annotated data-
set. The current estimate indicates that the haploid genome 
of T. cruzi contains about 12,000 protein-coding genes. A 
total of 594 RNA genes were identified in this dataset and 
another 1400 RNA genes in the unannotated contigs (El-
Sayed et al. 2005b). 
The putative function could be assigned to 50.8% of the 
predicted protein-coding genes on the basis of significant 
similarity to previously characterized proteins or known 
functional domains. 
 
Repetitive elements and retrotransposons 
modeled the T. cruzi genome 
 
One of the more challenging problems in assembling the T. 
cruzi genome was its repetitive nature. In fact, the genome 
was annotated as individual large scaffolds but whole chro-
mosomes could not be reconstructed as in T. brucei and 
Leishmania. At least 50% of the genome is repetitive se-
quences, consisting mostly of large gene families of surface 
proteins, retrotransposons and subtelomeric repeats. 
Long terminal repeat (LTR) and non-LTR retroelements 
are abundant. The LTR retrotransposons are represented by 
SIRE and its associated element VIPER (Vazquez et al. 
2000) which have 480 and 275 highly conserved copies res-
pectively. However, degenerated copies of SIRE could ac-
count for 1500 to 2000 copies. 
The element SIRE is 430 bp long and dispersed through 
out the genome with presence in all chromosomes. SIRE is 
always inserted in polypyrimidine tracts in the intergenic 
regions and, as a consequence, it does not interrupt protein-
coding genes. In fact, SIRE was found transcribed always in 
sense orientation in 2.2% of the mRNAs as part of the 3′ 
UTR (Vazquez et al. 2000) and, at least, in one case as part 
of the 5′ UTR (Vazquez et al. 1994; Ben-Dov et al. 2005). 
It was demonstrated that SIRE harbors a weak but func-
tional trans-splicing signal that modulates expression of a 
ribosomal protein gene (Ben-Dov et al. 2005). Moreover, it 
was suggested that transcription as part of the 3′ UTRs 
could have a role in programmed gene regulation events but 
protein factors that bind SIRE sequences await identifica-
tion (Vazquez et al. 2000; D’Orso and Frasch 2001). 
VIPER was initially described as a 2326 bp long LTR-
like retroelement associated to SIRE (Fig. 5). VIPER begins 
with the first 182 bp of SIRE, whereas its 3′ end is formed 
by the last 220 bp of SIRE. Both SIRE moieties are connec-
ted by a 1924 bp segment that harbors an open reading 
frame coding for a complete reverse transcriptase-RNAse H 
protein with a 15 amino acids C-terminal sequence derived 
from the SIRE element. It was later found that this element 
is a truncated version of a larger VIPER (Fig. 5). The com-
plete VIPER is 4480 bp long and harbor three non-overlap-
ped domains encoding for a GAG-like, a tyrosine recombi-
nase and a reverse transcriptase-RNAse H proteins. On the 
basis of its reverse transcriptase phylogeny, it was estab-
lished that VIPER constitutes a novel group of tyrosine re-
combinase-enconding retrotransposons (Lorenzi et al. 2006). 
Interestingly, VIPER was found associated with strand-
switch regions of transcription in several chromosomes (Lo-
renzi et al. 2006). In this way, the VIPER-SIRE pair was 
demonstrated to have several consequences to the modeling, 
plasticity and expression of the T. cruzi genome. 
The NON-LTR retrotransposons are represented by 
members of CZAR, a site specific element inserted in the 
SL RNA loci (8 copies); L1Tc, an active retroelement with 
15 intact copies; and the nonautonomus NARTc, which 
seems to use the L1Tc machinery for retrotransposition (El-
Sayed et al. 2005b). Thus, VIPER-SIRE and L1Tc-NARTc 
seem to have the same relationship pattern in the genome 
(Fig. 5). 
It is worth noting that expansion of these repetitive ele-
ments in T. cruzi could be the result of the absence of active 
RNAi machinery in its genome since T. brucei uses RNAi to 
control the expression of the retroelements (Ullu et al. 
2004). 
 
Surface protein families are very large 
 
Besides the repetitive elements, the T. cruzi genome presen-
ted very large gene families such as the mucin and trans-sia-
lidase (TS) families with 863 and 1430 copies respectively. 
Most notably is the newly discovered MASP family of mu-
cin associated proteins with 1377 members. Other expanded 
families are the surface protein GP63 and the retroposon 
LTR Retrotransposon
NON-LTR Retrotransposon
VIPER (4.5 kb)
SIRE (0.43 kb)
L1Tc (4.9 kb)
NARTc (0.25 kb)
Fig. 5 Schematic representa-
tion of the two more relevant 
retrotransposon in the T. cruzi 
genome: SIRE-VIPER and 
NARTc-L1Tc. The numbers 
100% and 50% indicate se-
quence homology between the 
non-autonomous NARTc and 
the autonomous L1Tc. 
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hot-spot protein (RHS) with 425 and 752 members respec-
tively. The RHS protein function is unknown (El-Sayed et 
al. 2005b). 
The massive expansion of surface proteins genes in T. 
cruzi is interesting. The parasite is covered with mucins, 
which contribute to parasite protection and to the establish-
ment of a persistent infection. Mucins are glycoproteins 
that bear a dense array of O-linked oligosaccharides. It is 
suggested that they provide protection against the vector 
and/or vertebrate-host-derived defense mechanisms and en-
sure the targeting and invasion of specific cells (Buscaglia 
et al. 2006). 
The T. cruzi mucin repertoire stands out among the pro-
tozoan parasites for its complexity and versatility. They ac-
count for ~15% of all the predicted T. cruzi genes together 
with TS and MASPs, with which they are physically, and 
probably functionally, related. This fact highlights the im-
portance of these protein families in the parasite biology. 
Interestingly, they are all mostly telomeric. 
The transcription of mucin families is differential accor-
ding to the life cycle. The TcSMUG family of 30-50 kDa is 
preferentially expressed in the epimastigotes in the insect 
vector, and the TcMUC family of 60-200 kDa is expressed 
in the vertebrate host forms, amastigote and trypomastigote 
(Buscaglia et al. 2006). 
The largest superfamily is TS which is divided in two 
subfamilies. One subfamily includes 12 genes that enconde 
enzymatically active TSs. The remaining TS superfamily 
members consist of enzymatically inactive TS-like proteins 
with variable degrees of homology to the active ones. The 
significance sequence variability suggests a strong selective 
pressure on the TS family to diversify maybe in part due to 
the mammalian immune response (Buscaglia et al. 2006). 
The other superfamily, MASP, was previously unknown 
and discovered as part of the genome project. Most mem-
bers of this family are located downstream of TcMUC II 
mucin genes and that is why they are named mucin-associ-
ated surface proteins (MASP). However, they are resembled 
structurally and not at the sequence level. The central region 
of these proteins is highly variable and often contains repea-
ted sequences. An interesting observation is the existence of 
chimeras that contain the N- or C-terminal conserved do-
mains of MASP combined with the N- or C-terminal do-
main of mucin or the C-terminal domain from TS (El-Sayed 
et al. 2005b; Buscaglia et al. 2006). 
A common feature of these superfamilies is the presence 
of a large number of pseudogenes and they may contribute 
to diversity of the sequence repertoire through recombi-
nation events. 
Finally, all the information regarding T. cruzi genomic 
and post-genomics were assembled in an integrated data-
base named TcuziDB (http://tcruzidb.org). The TcruziDB 
has combined the annotation data with expression data (pro-
teomic and EST) and several search features in a relational 
architecture (Fig. 6). The database is growing constantly 
with the support of the research community that deposit 
functional genomic datasets (Aguero et al. 2006). 
 
Fig. 6 Frontpage of the TcruziDB website. TcruziDB is an integrated Trypanosoma cruzi genome resource that combines several search tools to perform 
data mining. It provides gene classifications and gene expression data such as ESTs and proteomic profiles in the three different life cycle stages of the 
parasite. http://tcruzidb.org (with kind permission). 
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COMPARATIVE GENOMICS OF THE TRITRYPS 
 
Although the Tritryps share many general characteristics, 
each is transmitted by a different insect, has its own life 
cycle features, different target tissues and distinct disease 
pathogenesis in their mammalian host. The availability of 
their genomes allowed a better understanding of the gene-
tic and evolutionary bases of these pathogens thorough 
comparative genomics. 
The genome of T. cruzi is the largest (67 Mb and 
12,000 genes) compared to T. brucei (35 Mb and 9068 
genes) and Leishmania (33 Mb and 8311 genes) which is 
also reflected in the larger number of protein-coding genes. 
The three genome contents were compared using the 
algorithm BlastP (basic local alignment search tool) and 
the mutual best hits between the three were grouped as 
clusters of orthologous groups (3-way COG). This defined 
the Tritryp core proteome which consist of 6158 members 
with several hundreds of hypothetical proteins with un-
known functions (Fig. 7). Several other proteins of the core 
proteome serve functions conserved in all eukaryotes such 
as DNA duplication, transcription, RNA processing, trans-
lation, DNA repair and many structural proteins (El-Sayed 
et al. 2005a). Of special importance are proteins of un-
known function shared by the three that could reveal clues 
to develop a single anti-parasitic drug that could kill any of 
the Tritryp pathogens. 
A total of 1014 2-way COGs were also defined (COGs 
shared by only two of the three Tritryps) with T. brucei and 
Leishmania sharing the less number of 2-way COGs (74), 
and T. cruzi/T. brucei and T. cruzi/Leishmania sharing si-
milar numbers (458 and 482, respectively) (Fig. 7). The 
larger number of species-specific members or 1-way COGs 
is present in T. cruzi (3736) compared to T. brucei (1392) 
and Leishmania (910) and is contributed mainly by the 
surface protein families (Fig. 7). 
Several examples of protein domains expansion and 
loss were also revealed. Many of these proteins appear to 
be involved in host interactions. T. cruzi has expanded bac-
terial neuraminidase, mucin-like glycoprotein, retroposon 
hot spot protein domain (RHS) and several RNA binding 
protein domains. Leishmania has reduced several protein-
protein interaction domains such as leucine-rich repeats 
(LRR) or tetratricopeptide repeats (PPR), this does not 
happen in T. cruzi and T. brucei. 
Despite having diverged 200-500 million years ago 
predating the emergence of mammals, the genomes of the 
Tritryp are highly syntenic (i.e. show conservation of gene 
order). Moreover, almost all of the 3-way COGs (94%) fall 
within regions of conserved synteny. The analysis of syn-
teny breakpoints showed that 40% were associated with 
family expansions, structural RNAs or retroelements inser-
tions (El-Sayed et al. 2005a). 
The high degree of synteny is most likely the reflection 
of their mode of polycistronic transcription and RNA pro-
cessing mechanisms. Since transcription initiation is postu-
lated to start only at few sites per chromosome, there may 
be a selective pressure against synteny breaks within poly-
cistronic gene clusters. 
The synteny always decreased towards the telomere 
and subtelomeric regions as a result of specific adaptations 
of these parasites to their survival strategies. Antigenic 
variation and diversity are characteristics of T. brucei and T. 
cruzi respectively and the presence of a large array of genes 
encoding surface proteins in or near telomeres is not ac-
cidental. Moreover, its correlation with several insertions of 
retrotransposons in these regions may enhance recombina-
tion frequency and provide for a rapid sequence variation 
needed for survival. Recombination at these sites is prefe-
rential because it prevents synteny breaks at the middle of a 
chromosome. 
Finally, the comparative genomics of Tritryps also re-
solved a long-standing issue that claims that these species 
are descended from an ancestor that contained a photosyn-
thetic endosymbiont. However, the authors found that the 
protein domain content of Tritryps is not consistent with 
large-scale horizontal transfer of genetic material from 
plants (El-Sayed et al. 2005a). 
 
CONCLUDING REMARKS: THE FUTURES OF T. 
CRUZI GENETICS AND DRUG DEVELOPMENT 
ARE ON A COLLISION PATH 
 
I have presented various examples that put trypanosomes at 
the edge of eukaryotic evolution with several unusual as-
pects of their molecular and cellular biology as the general 
rule while these features are, at best, the exception of the 
rule in other organisms. With such a plethora of potential 
drug targets derived from these aspects and a genome se-
quence finished, why we do not have a number of effective 
drugs in clinical trials for Chagas disease? 
I think of two possible explanations to answer this ques-
tion. 
On the one side is the limitation of tools to perform 
post-genomics and functional genomic studies in T. cruzi. 
As I mentioned before, T. cruzi lacks RNAi and this is a 
major limitation to analyze gene function in a wide scale. 
Moreover, other tools such as a powerful inducible system 
to use with dominant negative approaches have not been de-
veloped until recently. For that reason, this useful approach 
has yet to be tested consistently in the years to come. With-
out powerful functional genomic tools to enter the post-ge-
nome era, the analysis of putative drug targets will suffer an 
important delay until we could decipher completely these 
unusual mechanisms in T. cruzi. T. brucei is a step forward 
in this aspect but it may not be always a model for T. cruzi 
genetics. 
One the other side is the pharmaceutical industry and its 
lack of interest to invest in Chagas drug development be-
cause it is “a disease of the poor”. The governments of the 
affected developing countries need to move the disease 
higher up their priority list to find a solution to this conun-
drum. 
As Carolyn Ash and Barbara Jasny wisely stated in the 
introduction to the trypanosomatid genomes issue of Sci-
ence, “let’s hope the genomes will fuel this process”. 
 
 
 
 
T. cruzi COGs L. major COGs
T. brucei COGs
1392
9103736 482
458 74
6158
Fig. 1 Clusters of orthologue groups (COGs) classification in compa-
rative genomics of the Tritryps. The T. cruzi COGs are shaded in gray. 
The number of products in the core proteome (the 3-way COG) is under-
lined. 
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